New ideas for therapy in ALS: critical considerations.
Beghi
Ettore
E
Bendotti
Caterina
C
Mennini
Tiziana
T
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000378:metabolism; D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002443:Ceftriaxone / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004195:Disease Models, Animal; D027342:Excitatory Amino Acid Transporter 2 / Q000096:biosynthesis; D006801:Humans; D051379:Mice; D008822:Mice, Transgenic; D047090:beta-Lactams / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D027342:Excitatory Amino Acid Transporter 2; D047090:beta-Lactams; D002443:Ceftriaxone